McDaniel Terry & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $508K | Buy |
3,325
+156
| +5% | +$23.9K | 0.04% | 63 |
|
|
2025
Q4 | $437K | Sell |
3,169
-8
| -0.3% | -$1.05K | 0.04% | 62 |
|
|
2025
Q3 | $407K | Sell |
3,177
-323
| -9% | -$39.4K | 0.03% | 74 |
|
|
2025
Q2 | $424K | Sell |
3,500
-395
| -10% | -$44.5K | 0.03% | 69 |
|
|
2025
Q1 | $434K | Sell |
3,895
-45
| -1% | -$4.79K | 0.04% | 72 |
|
|
2024
Q4 | $383K | Sell |
3,940
-2,250
| -36% | -$240K | 0.03% | 75 |
|
|
2024
Q3 | $712K | Buy |
6,190
+370
| +6% | +$42K | 0.06% | 57 |
|
|
2024
Q2 | $620K | Sell |
5,820
-164
| -3% | -$16.5K | 0.05% | 59 |
|
|
2024
Q1 | $579K | Sell |
5,984
-5,527
| -48% | -$567K | 0.05% | 64 |
|
|
2023
Q4 | $1.16M | Hold |
11,511
| – | – | 0.11% | 49 |
|
|
2023
Q3 | $1.17M | Hold |
11,511
| – | – | 0.12% | 48 |
|
|
2023
Q2 | $1.16M | Sell |
11,511
-12
| -0.1% | -$1.2K | 0.12% | 46 |
|
|
2023
Q1 | $1.06M | Sell |
11,523
-175
| -1% | -$15.3K | 0.12% | 42 |
|
|
2022
Q4 | $1.06M | Sell |
11,698
-590
| -5% | -$49.7K | 0.12% | 44 |
|
|
2022
Q3 | $934K | Sell |
12,288
-473
| -4% | -$39.2K | 0.12% | 43 |
|
|
2022
Q2 | $1.08M | Sell |
12,761
-5,861
| -31% | -$514K | 0.13% | 41 |
|
|
2022
Q1 | $1.63M | Sell |
18,622
-150,080
| -89% | -$13M | 0.18% | 39 |
|
|
2021
Q4 | $14.8M | Sell |
168,702
-43,773
| -21% | -$3.63M | 1.48% | 29 |
|
|
2021
Q3 | $17.4M | Buy |
212,475
+6,455
| +3% | +$581K | 2.03% | 24 |
|
|
2021
Q2 | $18.8M | Buy |
206,020
+2,861
| +1% | +$255K | 2.17% | 21 |
|
|
2021
Q1 | $17.4M | Buy |
203,159
+2,090
| +1% | +$188K | 2.13% | 23 |
|
|
2020
Q4 | $19M | Buy |
201,069
+3,981
| +2% | +$348K | 2.41% | 22 |
|
|
2020
Q3 | $17.1M | Buy |
197,088
+934
| +0.5% | +$80.9K | 2.43% | 20 |
|
|
2020
Q2 | $17.1M | Sell |
196,154
-5,066
| -3% | -$437K | 2.61% | 17 |
|
|
2020
Q1 | $16.6M | Buy |
201,220
+6,101
| +3% | +$544K | 3.05% | 15 |
|
|
2019
Q4 | $18.5M | Sell |
195,119
-1,744
| -0.9% | -$156K | 2.76% | 20 |
|
|
2019
Q3 | $17.1M | Sell |
196,863
-2,395
| -1% | -$215K | 2.75% | 21 |
|
|
2019
Q2 | $18.2M | Sell |
199,258
-21,587
| -10% | -$1.83M | 3.02% | 18 |
|
|
2019
Q1 | $19M | Buy |
220,845
+841
| +0.4% | +$67.5K | 3.26% | 16 |
|
|
2018
Q4 | $16.9M | Sell |
220,004
-749
| -0.3% | -$58.3K | 3.28% | 15 |
|
|
2018
Q3 | $17M | Buy |
220,753
+756
| +0.3% | +$55.9K | 2.88% | 21 |
|
|
2018
Q2 | $14.9M | Buy |
219,997
+2,252
| +1% | +$155K | 2.74% | 21 |
|
|
2018
Q1 | $15.8M | Sell |
217,745
-495
| -0.2% | -$37.7K | 2.88% | 20 |
|
|
2017
Q4 | $16.4M | Sell |
218,240
-624
| -0.3% | -$47.1K | 2.9% | 20 |
|
|
2017
Q3 | $16.8M | Sell |
218,864
-6,194
| -3% | -$468K | 3.18% | 20 |
|
|
2017
Q2 | $16.8M | Buy |
225,058
+396
| +0.2% | +$28.1K | 3.27% | 20 |
|
|
2017
Q1 | $15M | Buy |
224,662
+8,383
| +4% | +$559K | 2.93% | 22 |
|
|
2016
Q4 | $14.1M | Buy |
216,279
+163
| +0.1% | +$10.6K | 2.93% | 22 |
|
|
2016
Q3 | $15.3M | Buy |
216,116
+1,716
| +0.8% | +$125K | 3.27% | 18 |
|
|
2016
Q2 | $15.9M | Buy |
214,400
+3,674
| +2% | +$254K | 3.56% | 16 |
|
|
2016
Q1 | $13.7M | Buy |
210,726
+9,578
| +5% | +$652K | 3.22% | 23 |
|
|
2015
Q4 | $15.5M | Sell |
201,148
-954
| -0.5% | -$75.8K | 4.04% | 14 |
|
|
2015
Q3 | $16.6M | Buy |
202,102
+2,511
| +1% | +$223K | 4.64% | 8 |
|
|
2015
Q2 | $17.6M | Buy |
199,591
+3,731
| +2% | +$342K | 4.43% | 7 |
|
|
2015
Q1 | $17.3M | Buy |
195,860
+1,225
| +0.6% | +$109K | 4.23% | 10 |
|
|
2014
Q4 | $16.2M | Buy |
194,635
+1,913
| +1% | +$159K | 3.82% | 14 |
|
|
2014
Q3 | $16.3M | Sell |
192,722
-2,651
| -1% | -$214K | 3.89% | 12 |
|
|
2014
Q2 | $15.8M | Buy |
195,373
+1,682
| +0.9% | +$132K | 3.77% | 13 |
|
|
2014
Q1 | $14.8M | Buy |
193,691
+1,280
| +0.7% | +$93.3K | 3.75% | 13 |
|
|
2013
Q4 | $13.9M | Buy |
192,411
+11,559
| +6% | +$804K | 3.5% | 18 |
|
|
2013
Q3 | $12.4M | Buy |
180,852
+2,806
| +2% | +$186K | 3.41% | 15 |
|
|
2013
Q2 | $11.3M | Buy |
+178,046
| New | +$11.6M | 3.35% | 13 |
|
Other funds holding NVS
McDaniel Terry & Co's NVS Position: Q1 2026 in Review
McDaniel Terry & Co increased its Novartis (NVS) stake by 4.9% in Q1 2026, buying an estimated $23.9K and bringing the position to 3,325 shares worth $508K. The position accounts for 0.04% of the portfolio, ranked #63.
McDaniel Terry & Co first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $19M in Q1 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- McDaniel Terry & Co held 3,325 shares of Novartis worth $508K as of Q1 2026.
- McDaniel Terry & Co bought 156 Novartis shares in Q1 2026, an estimated $23.9K.
- Novartis made up 0.04% of McDaniel Terry & Co's portfolio in Q1 2026, its #63 holding.
- McDaniel Terry & Co first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- McDaniel Terry & Co's Novartis position peaked at $19M in Q1 2019.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on McDaniel Terry & Co's 13F filing for Q1 2026, filed 5 May 2026.